A Closer Look at Metabolic Parameters and Weight Changes in Atypical Antipsychotic Treatment of Schizophrenia

03/10/2025

The use of atypical antipsychotics in the treatment of schizophrenia can be associated with changes in metabolic parameters and weight. This video reviews the safety data on metabolic and weight changes from key clinical trials for schizophrenia to help healthcare providers understand these potential adverse events.

Watch the major depressive disorder video here and the bipolar I disorder video here.

This resource is intended for educational purposes only and is intended for US healthcare professionals. Healthcare professionals should use independent medical judgment. All decisions regarding patient care must be handled by a healthcare professional and be made based on the unique needs of each patient.

VRLR-US-00016-MC, V1.0
Approved 02/2025
AbbVie Medical Affairs

Andrew Cutler, MD

Clinical associate professor of psychiatry at State University of New York Upstate Medical University in Syracuse, New York, and chief medical officer of the Neuroscience Education Institute in Carlsbad, California

Roger McIntyre, MD, FRCPC

Professor of psychiatry and pharmacology at the University of Toronto and a practicing clinical psychiatrist

A Closer Look at Metabolic Parameters and Weight Changes in Atypical Antipsychotic Treatment of Schizophrenia

More from the series:

Specialties

Events

Year Round Education

HMP Global Products